Cargando…
CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer
SIMPLE SUMMARY: CEMIP (cell migration-inducing and hyaluronan-binding protein) has been implicated in the pathogenesis of numerous diseases, including colorectal and other forms of cancer. The molecular functions of CEMIP are currently under investigation and include the degradation of the extracell...
Autores principales: | Domanegg, Kevin, Sleeman, Jonathan P., Schmaus, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600181/ https://www.ncbi.nlm.nih.gov/pubmed/36291875 http://dx.doi.org/10.3390/cancers14205093 |
Ejemplares similares
-
CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
por: Cheng, Jun, et al.
Publicado: (2022) -
High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
por: Dong, Xingxing, et al.
Publicado: (2021) -
CEMIP as a potential biomarker and therapeutic target for breast cancer patients
por: Xue, Jinqi, et al.
Publicado: (2022) -
Increased Circulating Osteopontin Levels Promote Primary Tumour Growth, but Do Not Induce Metastasis in Melanoma
por: Saup, Rafael, et al.
Publicado: (2023) -
CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia
por: Banach, Anna, et al.
Publicado: (2019)